Erwinase Master Treatment Protocol

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05959720` - Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil
Recruiting	`NCT02933333` - G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor	Phase 4
Completed	`NCT02953730` - The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents	Phase 4
Completed	`NCT02767388` - Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery
Recruiting	`NCT03610438` - Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic Leukemia	Phase 2
Recruiting	`NCT05792007` - Study of the Medullary Microenvironment in Acute Childhood Leukemia	N/A
Completed	`NCT02294552` - Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT	Phase 2
Completed	`NCT01461538` - Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies	Phase 2
Recruiting	`NCT04167683` - Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant
Recruiting	`NCT05150561` - Muscle Dysfunction in Patients With Haematological Diseases
Active, not recruiting	`NCT04669210` - PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT	Phase 2
Recruiting	`NCT04013685` - Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies	Phase 1
Recruiting	`NCT02345915` - Evaluation of Adverse Long-term Effects in Young Adult Survivors of Acute Leukemia	N/A
Completed	`NCT01720264` - Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant	Phase 2
Not yet recruiting	`NCT02413021` - The Effect of Deferasirox on Response Rate of Acute Leukemia Patients Not Treated by Standard Chemotherapy Regimens	Phase 1
Active, not recruiting	`NCT04778579` - Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy	Phase 2
Recruiting	`NCT03448393` - CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies	Phase 1
Completed	`NCT03833180` - A Study of Zilovertamab Vedotin (MK-2140) (VLS-101) in Participants With Hematologic Malignancies (MK-2140-001)	Phase 1
Active, not recruiting	`NCT03367299` - Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia	Phase 2
Terminated	`NCT02435550` - iCare for Cancer Patients	N/A

NCT number	NCT00590915
Study type	Expanded Access
Source	Phoenix Children's Hospital
Contact
Status	No longer available
Phase	N/A

Erwinase Master Treatment Protocol — EMTP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms